At a glance
ClinicalIndex Comparison RecordN/ACompleted· 66 enrolled
Drug / intervention
Bone Marrow Concentrate +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Bone Marrow Concentrate Intradiscal Injection for Chronic Discogenic Low Back Pain: A Double-Blind, Placebo Controlled Trial
In Brief
A clinical study evaluating Bone Marrow Concentrate and Placebo for Discogenic Pain. Completed, enrolled 66 participants across 1 site.
Detailed Summary
A double-blind, placebo-controlled study to determine the efficacy of intradiscal injection of bone marrow concentrate on discogenic low back pain.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiscogenic Pain
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedNov 2017
Enrollment StartAug 2018
Primary CompletionAug 2024
TodayJul 2026
First PostedNov 14, 2017
Enrollment StartAug 1, 2018
Primary CompletionAug 7, 2024
TodayJul 2, 2026
Enrollment to primary: 6.0 yearsPosted 8.6 years ago
Interventions
Bone Marrow Concentrateother
Bone marrow concentrate is bone marrow harvested from the iliac crest and minimally processed in a centrifuge. It is then injected into the suspected painful disc (s) using fluoroscopic guidance
Placeboother
Injection of normal saline dorsal to the transverse process after sham bone marrow aspiration